Opioids News and Research

RSS
An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. The receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.
YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

Physician experts review current practices for pain management in cirrhotic patients

Physician experts review current practices for pain management in cirrhotic patients

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Elite Pharmaceuticals acquires hydromorphone hydrochloride tablets from Mikah Pharma

Elite Pharmaceuticals acquires hydromorphone hydrochloride tablets from Mikah Pharma

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

Use of life-ending drugs without explicit patient request occurs in hospital, among elderly patients

Use of life-ending drugs without explicit patient request occurs in hospital, among elderly patients

Research findings help explain diverse genetic susceptibility for alcohol use disorders

Research findings help explain diverse genetic susceptibility for alcohol use disorders

Warnings about a ruined appearance is best way to reduce tanning salon visits

Warnings about a ruined appearance is best way to reduce tanning salon visits

FDA approves ROXRO PHARMA's SPRIX Nasal Spray

FDA approves ROXRO PHARMA's SPRIX Nasal Spray

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Pain rehabilitation programs can help patients break the cycle of worsening pain: Mayo Clinic Health Letter

Pain rehabilitation programs can help patients break the cycle of worsening pain: Mayo Clinic Health Letter

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

QRxPharma reports successful outcome of Phase 1 trial for MoxDuo CR for chronic pain

QRxPharma reports successful outcome of Phase 1 trial for MoxDuo CR for chronic pain

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

Distinct gender differences underlying risks for abuse of prescription pain drugs: Study

Distinct gender differences underlying risks for abuse of prescription pain drugs: Study

Stinging FDA review for Acurox – the implications

Stinging FDA review for Acurox – the implications

Covidien launches EXALGO Extended-Release Tablets in the US

Covidien launches EXALGO Extended-Release Tablets in the US